 BeyondSpring Inc NASDAQ: BYSI plans to reduce its U.S. workforce by 35, including reassignment of certain personnel to subsidiaries, which is expected to result in cost savings that will extend the cash runway. The reorganization follows the FDA Complete Response Letter for plinabulin marketing application to prevent chemotherapy-induced neutropenia CIN. 